Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer

Part of paid clinical trials in Providence, Rhode Island.

Sponsor
Women and Infants Hospital of Rhode Island
Study ID
NCT00106262
Phase
PHASE2
Status
Terminated

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

This study is conducting an evaluation of two chemotherapy drugs, Velcade and Irinotecan, in women with advanced, recurrent, or metastatic cervical cancer, vaginal cancer, or vulvar cancer. Patients with cervical cancer may have received a platinum-containing treatment as systemic therapy without radiation, but is not required.

Key Dates

Start date
Mar 31, 2005
Status verified
Apr 2007
Completion
Mar 31, 2007

Study Design

Enrollment
38 participants
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

overall response rate

Locations (1)

FacilityCityStateZIPSite coordinators
Women & Infants' HospitalProvidenceRhode Island02905-

Find similar trials in Providence, RI

By condition
Cervical cancer
By specialty
OncologyGynecologic oncologyWomen's health
By research site
Women & Infants' Hospital· Providence, RI

Related Studies